首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1859042

治疗性血液分离术市场报告：趋势、预测和竞争分析（至2031年）

Therapeutic Apheresis Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: 2025年11月03日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录图表

全球治疗性血液分离术市场前景广阔，在医院和诊所市场蕴藏着巨大机会。预计2025年至2031年，全球治疗性血液分离术市场将以6.7%的复合年增长率成长。推动该市场发展的关键因素包括自体免疫血液疾病盛行率的上升、对先进血液分离术的需求不断增长以及人们对血浆疗法益处的认识不断提高。

Lucintel预测，在预测期内，治疗性血浆置换将迎来高速成长。
以使用量计算，医院预计将出现更高的成长。
从区域来看，预计亚太地区在预测期内将达到最高成长。

治疗性血液分离术市场的新趋势

在技术进步和对各种疾病状况认识加深的推动下，治疗性血液分离术市场正经历显着的变革。这些新兴趋势正在提升血液分离术的精准性、可近性和适用性，为越来越多的疾病提供更具针对性和更有效的治疗方案。

选择性血液分离技术：目前的主要发展趋势是开发高选择性血液分离技术，该技术能够特异性清除血液中的致病物质（例如自体抗体、冷球蛋白、低密度脂蛋白胆固醇），同时保留有益成分。这种精准性提高了疗效，减少了副作用，拓宽了治疗应用范围，并最终改善了患者的治疗效果。
携带式分散式医疗：携带式血液分离机的普及使得门诊和居家治疗成为可能。这一趋势的驱动力在于，人们对以患者为中心的医疗模式的需求日益增长，这有助于减轻医院负担、提高患者依从性，并改善需要频繁治疗的慢性疾病患者的生活品质。
与细胞和基因疗法的整合：治疗性血液分离术与蓬勃发展的细胞和基因治疗领域日益紧密地联繫在一起，在收集特定细胞群（例如，CAR-T 疗法的 T 细胞、移植的干细胞）和处理细胞激素释放综合征等併发症发挥关键作用，巩固了其在先进个性化医疗中的地位。
自动化和智慧型设备：将自动化和人工智慧 (AI) 整合到血液分离系统中是关键趋势。自动化系统简化了复杂的操作流程，减少了人为错误，并提高了效率。人工智慧演算法优化了分离过程，确保了即时监测，并实现了个人化的治疗调整，从而提高了患者的安全性和治疗效果。
治疗应用范围扩大：治疗性血液分离术的应用范围已从传统的血液学和神经病学领域扩展到脓毒症治疗、器官移植（去除供体特异性抗体）、某些肿瘤治疗等新领域。适应症的多样化显着扩大了市场潜力，并推动了对先进系统的需求。

这些新兴趋势正在显着地重塑治疗性血液分离市场，使治疗更加精准、便捷，并与尖端医疗相结合，从而实现个人化医疗，提高患者的便利性，并扩大血液分离可有效治疗的疾病范围，进而推动市场显着增长。

治疗性血液分离市场的最新趋势

近年来，受疾病种类不断增多和技术持续创新的推动，治疗性血液分离术市场发生了显着变化。这些进步带来了更有效率、更精准、更便利的治疗方案，显着改善了多种疾病患者的治疗效果。

先进设备平台：推出新一代血液分离系统，该系统具备自动化、使用者友善介面和更高安全性。例如，百特国际的PrisMax系统为多种器官支持疗法（包括血液分离）提供了一个多功能平台，可简化流程并提高重症加护环境的效率。
标靶吸附技术：开发专门设计的吸附柱和过滤器，用于高度选择性地去除特定病原体，从而能够精确去除自体免疫疾病中的自身抗体和遗传性高胆固醇症中的低密度脂蛋白胆固醇，进而实现更有针对性和更有效的治疗。
关注镰状细胞疾病：加大对治疗性血液分离术（尤其是红血球置换术）的关注和投入，以治疗镰状细胞疾病。随着Terumo Corporation血液与细胞技术公司在各地实施旨在改善镰状细胞疾病患者护理的项目，血液分离术作为该疾病的重要治疗方法正日益受到认可。
与细胞和基因治疗工作流程的整合：血球分离设备製造商与细胞和基因治疗开发商之间的合作日益密切，旨在优化细胞采集流程。这确保了特定细胞类型的高效、高品质采集——这是个人化细胞疗法生产的关键步骤——并推动了这些领域交叉领域的创新。
分散式门诊病人治疗方案：开发可在传统医院环境之外（例如门诊诊所或家中）进行治疗的血液分离术方案。这一趋势满足了患者对舒适性和便利性的日益增长的需求，减轻了医院的负担，并提高了需要频繁治疗的慢性病患者的就医便利性。

这些近期趋势共同影响着治疗性血液分离术市场，提高了治疗的准确性和效率，扩大了其对更广泛疾病的适用范围，并改善了患者的就医便利性，进而推动了创新和应用，最终改善了患者的治疗效果，并实现了市场的持续增长。

概述
亚太地区治疗性血液分离市场（按类型划分）
亚太地区治疗性血液分离市场（按应用划分）
日本治疗性血液分离术市场
印度治疗性血液分离术市场
中国治疗性血液分离市场
韩国治疗性血液分离术市场
印尼治疗性血液分离市场

10. 其他地区（ROW）治疗性血液分离市场

概述
ROW治疗性血液分离市场按类型划分
按应用领域分類的 ROW 治疗性血液分离市场
中东治疗性血液分离市场
南美洲治疗性血液分离市场
非洲治疗性血液分离市场

第十一章竞争分析

产品系列分析
营运整合
波特五力分析
- 竞争对手之间的竞争
- 买方议价能力
- 供应商的议价能力
- 替代品的威胁
- 新进入者的威胁
市占率分析

第十二章：机会与策略分析

价值链分析
成长机会分析
- 按类型分類的成长机会
- 透过申请获得发展机会
全球治疗性血液分离市场的新趋势
战略分析
- 新产品开发
- 认证和许可
- 企业合併、协议、合作关係和合资企业

第十三章：价值链中主要企业的概况

竞争分析
Miltenyi Biotec
Fresenius
Terumo
Baxter
Medica Group

第十四章附录

图表清单
表格列表
分析方法
免责声明
版权
简称和技术单位
关于 Lucintel
询问

简介目录图表

The future of the global therapeutic apheresis market looks promising with opportunities in the hospital and clinic markets. The global therapeutic apheresis market is expected to grow with a CAGR of 6.7% from 2025 to 2031. The major drivers for this market are the increasing prevalence of autoimmune blood disorders, the rising demand for advanced apheresis procedures, and the growing awareness of plasma therapy benefits.

Lucintel forecasts that, within the type category, therapeutic plasma exchange is expected to witness higher growth over the forecast period.
Within the application category, hospital is expected to witness higher growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Therapeutic Apheresis Market

The therapeutic apheresis market is undergoing significant evolution, driven by technological advancements and a deeper understanding of various disease pathologies. These emerging trends are enhancing the precision, accessibility, and applicability of apheresis, leading to more targeted and effective treatments for a growing range of medical conditions.

Selective Apheresis Techniques: A key trend is the development of highly selective apheresis techniques that can specifically remove pathogenic substances (e.g., autoantibodies, cryoglobulins, LDL cholesterol) from the blood, while preserving beneficial components. This precision enhances efficacy, reduces side effects, and broadens therapeutic applications, leading to improved patient outcomes.
Portable and Decentralized Care: There's a growing shift towards portable apheresis devices and enabling treatments in outpatient settings or even at home. This trend is driven by the increasing demand for patient-centric care models, reducing the burden on hospitals, improving patient compliance, and enhancing the quality of life for chronic care patients requiring frequent treatments.
Integration with Cell and Gene Therapies: Therapeutic apheresis is becoming increasingly intertwined with the burgeoning field of cell and gene therapies. It plays a crucial role in collecting specific cell populations (e.g., T-cells for CAR-T therapy, stem cells for transplantation) and in managing complications like cytokine release syndrome, cementing its role in advanced personalized medicine.
Automation and Smart Devices: The integration of automation and artificial intelligence (AI) into apheresis systems is a significant trend. Automated systems simplify complex procedures, reduce human error, and enhance efficiency. AI algorithms can optimize separation processes, ensure real-time monitoring, and enable personalized treatment adjustments, improving patient safety and outcomes.
Expanded Therapeutic Applications: Beyond traditional uses in hematology and neurology, therapeutic apheresis is finding expanded applications in new areas, including sepsis management, organ transplantation (removing donor-specific antibodies), and certain oncology treatments. This diversification of indications is significantly broadening the market potential and driving demand for advanced systems.

These emerging trends are profoundly reshaping the therapeutic apheresis market by making treatments more precise, accessible, and integrated with cutting-edge medical advancements. They are enabling personalized care, improving patient convenience, and expanding the range of conditions effectively treatable with apheresis, thereby driving significant market growth.

Recent Developments in the Therapeutic Apheresis Market

The therapeutic apheresis market has witnessed a surge of transformative developments recently, fueled by increasing disease prevalence and continuous technological innovation. These advancements are leading to more efficient, precise, and accessible treatments, significantly improving patient outcomes for a wide array of conditions.

Advanced Device Platforms: Introduction of next-generation apheresis systems with enhanced automation, user-friendly interfaces, and improved safety features. For example, Baxter International's PrisMax system offers a versatile platform for various organ support therapies, including apheresis, streamlining procedures and increasing efficiency in critical care settings.
Targeted Adsorption Technologies: Development of specialized adsorption columns and filters designed for highly selective removal of specific pathogenic substances. Innovations like specific immunoadsorbents enable precise elimination of autoantibodies in autoimmune diseases or LDL cholesterol in familial hypercholesterolemia, leading to more targeted and effective treatments.
Focus on Sickle Cell Disease: Increased emphasis and investment in therapeutic apheresis, particularly red blood cell exchange, for the management of sickle cell disease. Initiatives like Terumo Blood and Cell Technologies' programs to enhance care for sickle cell patients in various regions highlight a growing recognition of apheresis as a critical therapy for this condition.
Integration with Cell and Gene Therapy Workflows: Growing collaboration between apheresis device manufacturers and cell/gene therapy developers to optimize cell collection processes. This ensures efficient and high-quality collection of specific cell types, a crucial step in the manufacturing of personalized cellular therapies, driving innovation at the intersection of fields.
Decentralized and Outpatient Care Solutions: Development of apheresis solutions that facilitate treatment outside traditional hospital settings, such as in outpatient clinics or even at home. This trend addresses the growing demand for patient comfort and convenience, reducing hospital burden and improving accessibility for chronic patients requiring frequent sessions.

These recent developments are collectively impacting the therapeutic apheresis market by enhancing the precision and efficiency of treatments, expanding their applicability to a broader range of diseases, and improving patient access and convenience. They are driving innovation and adoption, ultimately leading to better patient outcomes and sustained market growth.

Strategic Growth Opportunities in the Therapeutic Apheresis Market

The therapeutic apheresis market offers substantial strategic growth opportunities across key applications, driven by the increasing incidence of chronic and autoimmune diseases and the growing demand for targeted therapies. Capitalizing on these opportunities requires focused innovation, market penetration strategies, and addressing specific clinical needs.

Neurological Disorders Treatment: The rising prevalence of neurological autoimmune diseases like Guillain-Barre syndrome, myasthenia gravis, and multiple sclerosis presents a significant growth opportunity. Developing and promoting apheresis solutions (especially Therapeutic Plasma Exchange) tailored for these conditions, with a focus on rapid intervention and improved outcomes, will be crucial.
Autoimmune Disease Management: The broad spectrum of autoimmune diseases (e.g., lupus, rheumatoid arthritis, vasculitis) where conventional treatments are insufficient or have severe side effects offers a vast market. Strategic growth lies in developing specialized apheresis techniques and devices that can effectively remove specific autoantibodies and immune complexes, providing a vital therapeutic option.
Oncology Support and Cell Therapy: The growing field of oncology, particularly with the advent of CAR-T cell therapies and other cell-based treatments, creates substantial opportunities. Apheresis plays a critical role in collecting effector cells for these therapies and managing their side effects, making it an indispensable component of modern cancer treatment protocols.
Renal Disease Management: The increasing global burden of chronic kidney disease and end-stage renal disease drives demand for apheresis in managing complications like hypercholesterolemia and certain forms of glomerulonephritis. Innovations in LDL apheresis and other specific filtration techniques for kidney patients represent a key growth area.
Transplant Medicine and Organ Rejection: Apheresis is crucial in solid organ transplantation to remove donor-specific antibodies (DSAs) that can lead to rejection, both pre- and post-transplant. Strategic growth involves enhancing apheresis technologies for effective DSA removal, improving graft survival, and expanding its use in challenging transplant scenarios.

These strategic growth opportunities are poised to profoundly impact the therapeutic apheresis market by driving specialized product development, expanding market penetration into high-value medical segments, and solidifying apheresis's role as a cornerstone therapy in various chronic and critical conditions.

Therapeutic Apheresis Market Driver and Challenges

The therapeutic apheresis market is characterized by a dynamic interplay of various technological, economic, and regulatory factors. Major drivers include the increasing prevalence of chronic and autoimmune diseases, advancements in apheresis technologies, and the growing demand for plasma-derived therapies. However, the market also faces significant challenges such as the high cost of procedures, the lack of skilled professionals, and stringent regulatory complexities.

The factors responsible for driving the therapeutic apheresis market include:

1. Rising Incidence of Chronic and Autoimmune Diseases: The escalating global prevalence of conditions like multiple sclerosis, lupus, Guillain-Barre syndrome, and various hematological disorders significantly drives the demand for therapeutic apheresis. These diseases often require apheresis as a primary or adjunctive treatment, expanding its clinical utility.

2. Technological Advancements in Apheresis Devices: Continuous innovation in apheresis equipment, including automated systems, enhanced membrane filtration techniques, and more selective adsorption columns. These advancements improve procedure efficiency, precision, and patient safety, making apheresis a more viable and attractive treatment option.

3. Growing Demand for Plasma-Derived Therapies: The increasing need for plasma-derived medicinal products (PDMPs) such as immunoglobulins, albumin, and clotting factors, largely collected through plasmapheresis. This consistent demand from the biopharmaceutical industry provides a strong underlying driver for the apheresis market.

4. Expansion of Therapeutic Applications: Beyond traditional uses, therapeutic apheresis is finding new applications in areas like sepsis management, organ transplantation (e.g., desensitization), and various oncological treatments. This diversification of indications broadens the market potential and drives further adoption.

5. Favorable Reimbursement Policies: In developed economies, favorable reimbursement policies and government support for apheresis procedures encourage healthcare providers to offer these therapies. This financial backing reduces the burden on patients and healthcare systems, thereby facilitating wider adoption.

Challenges in the therapeutic apheresis market are:

1. High Cost of Procedures and Equipment: The significant capital expenditure required for purchasing apheresis devices and the recurring costs of disposable kits and skilled personnel. This high cost can limit the accessibility of therapeutic apheresis, particularly in developing regions or for patients without adequate insurance coverage.

2. Lack of Skilled Professionals: The specialized nature of therapeutic apheresis procedures necessitates highly trained and skilled healthcare professionals (e.g., apheresis nurses, medical technologists). A shortage of such qualified personnel in many regions poses a significant challenge, impacting the capacity and quality of apheresis services.

3. Regulatory Complexities: Stringent and evolving regulatory frameworks for apheresis devices, consumables, and therapeutic applications. Navigating these complex approval processes can be time-consuming and costly for manufacturers, potentially delaying market entry for innovative products and limiting their widespread availability.

The therapeutic apheresis market is on a trajectory of robust growth, propelled by the rising global burden of chronic diseases and continuous technological innovations that enhance treatment efficacy. However, addressing the critical challenges of high costs, the shortage of skilled professionals, and regulatory complexities will be crucial to ensure broader patient access and unlock the full potential of these life-saving therapies.

List of Therapeutic Apheresis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies therapeutic apheresis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the therapeutic apheresis companies profiled in this report include-

Miltenyi Biotec
Fresenius
Terumo
Baxter
Medica Group

Therapeutic Apheresis Market by Segment

The study includes a forecast for the global therapeutic apheresis market by type, application, and region.

Therapeutic Apheresis Market by Type [Value from 2019 to 2031]:

Therapeutic Plasma Exchange
Red Blood Cell Exchange

Therapeutic Apheresis Market by Application [Value from 2019 to 2031]:

Hospital
Clinic
Others

Therapeutic Apheresis Market by Region [Value from 2019 to 2031]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Therapeutic Apheresis Market

Recent developments in the therapeutic apheresis market are transforming the treatment of numerous critical illnesses, from autoimmune disorders to neurological conditions. Driven by advancements in device technology, increasing prevalence of chronic diseases, and a shift towards personalized medicine, apheresis is becoming a cornerstone of modern treatment regimens, offering precise and targeted removal of harmful blood components.

United States: The U.S. market is a leader in therapeutic apheresis, characterized by significant investment in advanced systems and disposable kits. There's a strong focus on integration with cell and gene therapies, as well as developing portable devices for decentralized care, aiming to enhance patient access and improve treatment outcomes for complex diseases.
China: China's therapeutic apheresis market is experiencing rapid growth, fueled by rising healthcare expenditure and an increasing burden of chronic diseases. The country is investing in modernizing its healthcare infrastructure and increasing the adoption of advanced apheresis techniques for a wide range of applications, especially in hematology.
Germany: Germany's market emphasizes high-quality apheresis equipment and innovative therapeutic applications, driven by a robust healthcare system and stringent quality standards. There's a notable focus on immunoadsorption and specific apheresis techniques for autoimmune and neurological disorders, reflecting a strong research and development ecosystem.
India: India's therapeutic apheresis market is expanding swiftly, propelled by the growing incidence of chronic and autoimmune diseases and improving healthcare infrastructure. Increased awareness among medical professionals and the adoption of modern apheresis procedures are contributing to market growth, with a focus on affordability and accessibility.
Japan: Japan's therapeutic apheresis market is characterized by technological sophistication and a high adoption rate of advanced apheresis systems. Driven by its aging population and demand for specialized treatments, there's a continuous push for innovations in selective apheresis and integration with regenerative medicine, notably in areas like LDL apheresis.

Features of the Global Therapeutic Apheresis Market

Market Size Estimates: Therapeutic apheresis market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Therapeutic apheresis market size by type, application, and region in terms of value ($B).
Regional Analysis: Therapeutic apheresis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the therapeutic apheresis market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the therapeutic apheresis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the therapeutic apheresis market by type (therapeutic plasma exchange and red blood cell exchange), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Therapeutic Apheresis Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Therapeutic Plasma Exchange: Trends and Forecast (2019-2031)
4.4 Red Blood Cell Exchange: Trends and Forecast (2019-2031)

5. Global Therapeutic Apheresis Market by Application

5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Hospital: Trends and Forecast (2019-2031)
5.4 Clinic: Trends and Forecast (2019-2031)
5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

6.1 Overview
6.2 Global Therapeutic Apheresis Market by Region

7. North American Therapeutic Apheresis Market

7.1 Overview
7.2 North American Therapeutic Apheresis Market by Type
7.3 North American Therapeutic Apheresis Market by Application
7.4 United States Therapeutic Apheresis Market
7.5 Mexican Therapeutic Apheresis Market
7.6 Canadian Therapeutic Apheresis Market

8. European Therapeutic Apheresis Market

8.1 Overview
8.2 European Therapeutic Apheresis Market by Type
8.3 European Therapeutic Apheresis Market by Application
8.4 German Therapeutic Apheresis Market
8.5 French Therapeutic Apheresis Market
8.6 Spanish Therapeutic Apheresis Market
8.7 Italian Therapeutic Apheresis Market
8.8 United Kingdom Therapeutic Apheresis Market

9. APAC Therapeutic Apheresis Market

9.1 Overview
9.2 APAC Therapeutic Apheresis Market by Type
9.3 APAC Therapeutic Apheresis Market by Application
9.4 Japanese Therapeutic Apheresis Market
9.5 Indian Therapeutic Apheresis Market
9.6 Chinese Therapeutic Apheresis Market
9.7 South Korean Therapeutic Apheresis Market
9.8 Indonesian Therapeutic Apheresis Market

10. ROW Therapeutic Apheresis Market

10.1 Overview
10.2 ROW Therapeutic Apheresis Market by Type
10.3 ROW Therapeutic Apheresis Market by Application
10.4 Middle Eastern Therapeutic Apheresis Market
10.5 South American Therapeutic Apheresis Market
10.6 African Therapeutic Apheresis Market

11. Competitor Analysis

11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Application
12.3 Emerging Trends in the Global Therapeutic Apheresis Market
12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

13.1 Competitive Analysis
13.2 Miltenyi Biotec
- Company Overview
- Therapeutic Apheresis Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.3 Fresenius
- Company Overview
- Therapeutic Apheresis Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.4 Terumo
- Company Overview
- Therapeutic Apheresis Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.5 Baxter
- Company Overview
- Therapeutic Apheresis Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.6 Medica Group
- Company Overview
- Therapeutic Apheresis Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

14. Appendix

14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

简介目录图表

List of Figures

Figure 1.1: Trends and Forecast for the Global Therapeutic Apheresis Market
Figure 2.1: Usage of Therapeutic Apheresis Market
Figure 2.2: Classification of the Global Therapeutic Apheresis Market
Figure 2.3: Supply Chain of the Global Therapeutic Apheresis Market
Figure 3.1: Driver and Challenges of the Therapeutic Apheresis Market
Figure 3.2: PESTLE Analysis
Figure 3.3: Patent Analysis
Figure 3.4: Regulatory Environment
Figure 4.1: Global Therapeutic Apheresis Market by Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global Therapeutic Apheresis Market ($B) by Type
Figure 4.3: Forecast for the Global Therapeutic Apheresis Market ($B) by Type
Figure 4.4: Trends and Forecast for Therapeutic Plasma Exchange in the Global Therapeutic Apheresis Market (2019-2031)
Figure 4.5: Trends and Forecast for Red Blood Cell Exchange in the Global Therapeutic Apheresis Market (2019-2031)
Figure 5.1: Global Therapeutic Apheresis Market by Application in 2019, 2024, and 2031
Figure 5.2: Trends of the Global Therapeutic Apheresis Market ($B) by Application
Figure 5.3: Forecast for the Global Therapeutic Apheresis Market ($B) by Application
Figure 5.4: Trends and Forecast for Hospital in the Global Therapeutic Apheresis Market (2019-2031)
Figure 5.5: Trends and Forecast for Clinic in the Global Therapeutic Apheresis Market (2019-2031)
Figure 5.6: Trends and Forecast for Others in the Global Therapeutic Apheresis Market (2019-2031)
Figure 6.1: Trends of the Global Therapeutic Apheresis Market ($B) by Region (2019-2024)
Figure 6.2: Forecast for the Global Therapeutic Apheresis Market ($B) by Region (2025-2031)
Figure 7.1: North American Therapeutic Apheresis Market by Type in 2019, 2024, and 2031
Figure 7.2: Trends of the North American Therapeutic Apheresis Market ($B) by Type (2019-2024)
Figure 7.3: Forecast for the North American Therapeutic Apheresis Market ($B) by Type (2025-2031)
Figure 7.4: North American Therapeutic Apheresis Market by Application in 2019, 2024, and 2031
Figure 7.5: Trends of the North American Therapeutic Apheresis Market ($B) by Application (2019-2024)
Figure 7.6: Forecast for the North American Therapeutic Apheresis Market ($B) by Application (2025-2031)
Figure 7.7: Trends and Forecast for the United States Therapeutic Apheresis Market ($B) (2019-2031)
Figure 7.8: Trends and Forecast for the Mexican Therapeutic Apheresis Market ($B) (2019-2031)
Figure 7.9: Trends and Forecast for the Canadian Therapeutic Apheresis Market ($B) (2019-2031)
Figure 8.1: European Therapeutic Apheresis Market by Type in 2019, 2024, and 2031
Figure 8.2: Trends of the European Therapeutic Apheresis Market ($B) by Type (2019-2024)
Figure 8.3: Forecast for the European Therapeutic Apheresis Market ($B) by Type (2025-2031)
Figure 8.4: European Therapeutic Apheresis Market by Application in 2019, 2024, and 2031
Figure 8.5: Trends of the European Therapeutic Apheresis Market ($B) by Application (2019-2024)
Figure 8.6: Forecast for the European Therapeutic Apheresis Market ($B) by Application (2025-2031)
Figure 8.7: Trends and Forecast for the German Therapeutic Apheresis Market ($B) (2019-2031)
Figure 8.8: Trends and Forecast for the French Therapeutic Apheresis Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the Spanish Therapeutic Apheresis Market ($B) (2019-2031)
Figure 8.10: Trends and Forecast for the Italian Therapeutic Apheresis Market ($B) (2019-2031)
Figure 8.11: Trends and Forecast for the United Kingdom Therapeutic Apheresis Market ($B) (2019-2031)
Figure 9.1: APAC Therapeutic Apheresis Market by Type in 2019, 2024, and 2031
Figure 9.2: Trends of the APAC Therapeutic Apheresis Market ($B) by Type (2019-2024)
Figure 9.3: Forecast for the APAC Therapeutic Apheresis Market ($B) by Type (2025-2031)
Figure 9.4: APAC Therapeutic Apheresis Market by Application in 2019, 2024, and 2031
Figure 9.5: Trends of the APAC Therapeutic Apheresis Market ($B) by Application (2019-2024)
Figure 9.6: Forecast for the APAC Therapeutic Apheresis Market ($B) by Application (2025-2031)
Figure 9.7: Trends and Forecast for the Japanese Therapeutic Apheresis Market ($B) (2019-2031)
Figure 9.8: Trends and Forecast for the Indian Therapeutic Apheresis Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Chinese Therapeutic Apheresis Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the South Korean Therapeutic Apheresis Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the Indonesian Therapeutic Apheresis Market ($B) (2019-2031)
Figure 10.1: ROW Therapeutic Apheresis Market by Type in 2019, 2024, and 2031
Figure 10.2: Trends of the ROW Therapeutic Apheresis Market ($B) by Type (2019-2024)
Figure 10.3: Forecast for the ROW Therapeutic Apheresis Market ($B) by Type (2025-2031)
Figure 10.4: ROW Therapeutic Apheresis Market by Application in 2019, 2024, and 2031
Figure 10.5: Trends of the ROW Therapeutic Apheresis Market ($B) by Application (2019-2024)
Figure 10.6: Forecast for the ROW Therapeutic Apheresis Market ($B) by Application (2025-2031)
Figure 10.7: Trends and Forecast for the Middle Eastern Therapeutic Apheresis Market ($B) (2019-2031)
Figure 10.8: Trends and Forecast for the South American Therapeutic Apheresis Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the African Therapeutic Apheresis Market ($B) (2019-2031)
Figure 11.1: Porter's Five Forces Analysis of the Global Therapeutic Apheresis Market
Figure 11.2: Market Share (%) of Top Players in the Global Therapeutic Apheresis Market (2024)
Figure 12.1: Growth Opportunities for the Global Therapeutic Apheresis Market by Type
Figure 12.2: Growth Opportunities for the Global Therapeutic Apheresis Market by Application
Figure 12.3: Growth Opportunities for the Global Therapeutic Apheresis Market by Region
Figure 12.4: Emerging Trends in the Global Therapeutic Apheresis Market

List of Tables

Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Therapeutic Apheresis Market by Type and Application
Table 1.2: Attractiveness Analysis for the Therapeutic Apheresis Market by Region
Table 1.3: Global Therapeutic Apheresis Market Parameters and Attributes
Table 3.1: Trends of the Global Therapeutic Apheresis Market (2019-2024)
Table 3.2: Forecast for the Global Therapeutic Apheresis Market (2025-2031)
Table 4.1: Attractiveness Analysis for the Global Therapeutic Apheresis Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Therapeutic Apheresis Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Type in the Global Therapeutic Apheresis Market (2025-2031)
Table 4.4: Trends of Therapeutic Plasma Exchange in the Global Therapeutic Apheresis Market (2019-2024)
Table 4.5: Forecast for Therapeutic Plasma Exchange in the Global Therapeutic Apheresis Market (2025-2031)
Table 4.6: Trends of Red Blood Cell Exchange in the Global Therapeutic Apheresis Market (2019-2024)
Table 4.7: Forecast for Red Blood Cell Exchange in the Global Therapeutic Apheresis Market (2025-2031)
Table 5.1: Attractiveness Analysis for the Global Therapeutic Apheresis Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Therapeutic Apheresis Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Application in the Global Therapeutic Apheresis Market (2025-2031)
Table 5.4: Trends of Hospital in the Global Therapeutic Apheresis Market (2019-2024)
Table 5.5: Forecast for Hospital in the Global Therapeutic Apheresis Market (2025-2031)
Table 5.6: Trends of Clinic in the Global Therapeutic Apheresis Market (2019-2024)
Table 5.7: Forecast for Clinic in the Global Therapeutic Apheresis Market (2025-2031)
Table 5.8: Trends of Others in the Global Therapeutic Apheresis Market (2019-2024)
Table 5.9: Forecast for Others in the Global Therapeutic Apheresis Market (2025-2031)
Table 6.1: Market Size and CAGR of Various Regions in the Global Therapeutic Apheresis Market (2019-2024)
Table 6.2: Market Size and CAGR of Various Regions in the Global Therapeutic Apheresis Market (2025-2031)
Table 7.1: Trends of the North American Therapeutic Apheresis Market (2019-2024)
Table 7.2: Forecast for the North American Therapeutic Apheresis Market (2025-2031)
Table 7.3: Market Size and CAGR of Various Type in the North American Therapeutic Apheresis Market (2019-2024)
Table 7.4: Market Size and CAGR of Various Type in the North American Therapeutic Apheresis Market (2025-2031)
Table 7.5: Market Size and CAGR of Various Application in the North American Therapeutic Apheresis Market (2019-2024)
Table 7.6: Market Size and CAGR of Various Application in the North American Therapeutic Apheresis Market (2025-2031)
Table 7.7: Trends and Forecast for the United States Therapeutic Apheresis Market (2019-2031)
Table 7.8: Trends and Forecast for the Mexican Therapeutic Apheresis Market (2019-2031)
Table 7.9: Trends and Forecast for the Canadian Therapeutic Apheresis Market (2019-2031)
Table 8.1: Trends of the European Therapeutic Apheresis Market (2019-2024)
Table 8.2: Forecast for the European Therapeutic Apheresis Market (2025-2031)
Table 8.3: Market Size and CAGR of Various Type in the European Therapeutic Apheresis Market (2019-2024)
Table 8.4: Market Size and CAGR of Various Type in the European Therapeutic Apheresis Market (2025-2031)
Table 8.5: Market Size and CAGR of Various Application in the European Therapeutic Apheresis Market (2019-2024)
Table 8.6: Market Size and CAGR of Various Application in the European Therapeutic Apheresis Market (2025-2031)
Table 8.7: Trends and Forecast for the German Therapeutic Apheresis Market (2019-2031)
Table 8.8: Trends and Forecast for the French Therapeutic Apheresis Market (2019-2031)
Table 8.9: Trends and Forecast for the Spanish Therapeutic Apheresis Market (2019-2031)
Table 8.10: Trends and Forecast for the Italian Therapeutic Apheresis Market (2019-2031)
Table 8.11: Trends and Forecast for the United Kingdom Therapeutic Apheresis Market (2019-2031)
Table 9.1: Trends of the APAC Therapeutic Apheresis Market (2019-2024)
Table 9.2: Forecast for the APAC Therapeutic Apheresis Market (2025-2031)
Table 9.3: Market Size and CAGR of Various Type in the APAC Therapeutic Apheresis Market (2019-2024)
Table 9.4: Market Size and CAGR of Various Type in the APAC Therapeutic Apheresis Market (2025-2031)
Table 9.5: Market Size and CAGR of Various Application in the APAC Therapeutic Apheresis Market (2019-2024)
Table 9.6: Market Size and CAGR of Various Application in the APAC Therapeutic Apheresis Market (2025-2031)
Table 9.7: Trends and Forecast for the Japanese Therapeutic Apheresis Market (2019-2031)
Table 9.8: Trends and Forecast for the Indian Therapeutic Apheresis Market (2019-2031)
Table 9.9: Trends and Forecast for the Chinese Therapeutic Apheresis Market (2019-2031)
Table 9.10: Trends and Forecast for the South Korean Therapeutic Apheresis Market (2019-2031)
Table 9.11: Trends and Forecast for the Indonesian Therapeutic Apheresis Market (2019-2031)
Table 10.1: Trends of the ROW Therapeutic Apheresis Market (2019-2024)
Table 10.2: Forecast for the ROW Therapeutic Apheresis Market (2025-2031)
Table 10.3: Market Size and CAGR of Various Type in the ROW Therapeutic Apheresis Market (2019-2024)
Table 10.4: Market Size and CAGR of Various Type in the ROW Therapeutic Apheresis Market (2025-2031)
Table 10.5: Market Size and CAGR of Various Application in the ROW Therapeutic Apheresis Market (2019-2024)
Table 10.6: Market Size and CAGR of Various Application in the ROW Therapeutic Apheresis Market (2025-2031)
Table 10.7: Trends and Forecast for the Middle Eastern Therapeutic Apheresis Market (2019-2031)
Table 10.8: Trends and Forecast for the South American Therapeutic Apheresis Market (2019-2031)
Table 10.9: Trends and Forecast for the African Therapeutic Apheresis Market (2019-2031)
Table 11.1: Product Mapping of Therapeutic Apheresis Suppliers Based on Segments
Table 11.2: Operational Integration of Therapeutic Apheresis Manufacturers
Table 11.3: Rankings of Suppliers Based on Therapeutic Apheresis Revenue
Table 12.1: New Product Launches by Major Therapeutic Apheresis Producers (2019-2024)
Table 12.2: Certification Acquired by Major Competitor in the Global Therapeutic Apheresis Market

02-2729-4219

+886-2-2729-4219

License/价格

治疗性血液分离术市场报告：趋势、预测和竞争分析（至2031年）

Therapeutic Apheresis Market Report: Trends, Forecast and Competitive Analysis to 2031

目录

第一章执行摘要

第二章市场概览

第三章：市场趋势与预测分析

4. 全球治疗性血液分离市场（按类型划分）

5. 全球治疗性血液分离市场（按应用领域划分）

第六章区域分析

7. 北美治疗性血液分离市场

8. 欧洲治疗性血液分离市场

9. 亚太地区治疗性血液分离市场